Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02600520Phase 3Completed
A Phase 3 trial of rosuvastatin 1.2% in situ gel, atorvastatin 1.2% gel in chronic periodontitis, sponsored by Government Dental College and Research Institute. Started Nov 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02600520.